How big is KATE Therapeutics Inc.'s plan?

KATE Therapeutics Inc.'s plan reported $2.2M in assets and 53 participants for 2024.

Original filing (PDF)20250710132218NAL0008723824001

KATE Therapeutics Inc.

Name: KATE Therapeutics Inc. — KATE Therapeutics 401 K, Form 5500 (2024)
Creator: KATE Therapeutics Inc.
License: https://www.usa.gov/government-works

Form 5500-SF

FILING_RECEIVED

KATE Therapeutics 401 K Plan

401(k) retirement plan · KATE Therapeutics Inc.'s KATE Therapeutics 401 K Plan held $2.2M in plan assets for 53 participants in 2024.

Active participants

Accounts w/ balance

Plan assets (EOY)

$2.2M

Net assets (EOY)

$2.2M

People on this filing

Alexandra Edery signed KATE Therapeutics Inc.'s 2024 Form 5500 as plan administrator.

Alexandra Edery — Plan Administrator — Form 5500 signer

Get verified email & phone for these signers

Signer names are public record from the Form 5500 e-signature.

Plan identifiers

KATE Therapeutics Inc.'s EIN is 85-2929815.

EIN 85-2929815

Plan number 001

Plan year 2024

ACK ID 20250710132218NAL0008723824001

Official Form 5500 document

Download the official 2024 Form 5500 (PDF) for KATE Therapeutics Inc. from the U.S. Department of Labor's EFAST2 system.

Download the official 2024 Form 5500 (PDF)

Plan features

KATE Therapeutics Inc.'s plan includes profit-sharing, ERISA 404(c) participant direction, a 401(k) feature, automatic enrollment, a default investment (QDIA).

Decision-maker contacts

One unlock reveals every key decision-maker — plan signer, CFO, HR & Benefits — with verified email + LinkedIn for KATE THERAPEUTICS INC.

Finding similar companies…

Plan health score

Above-average plan

Directional indicator from public Form 5500 data — compliance & integrity, total plan cost, participant health and vendor stack, benchmarked against same-size peers. Not a fiduciary tool. Based on 70% of scoring inputs for this filing.

Compliance & integrity

100

Total plan cost

n/a

Plan health

Vendor & structure

100

Helping the score